Reporting owner · Q3 2026 · CIK 1612571

Ford Robert B: insider trades.

Ford Robert B reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($46.2M), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
2
Companies
1
Name as filed
Ford Robert B

Companies

CompanyRelationshipTransactions
Abbott Laboratories (ABT)Director, Officer · CHAIRMAN AND CEO4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-25Abbott LaboratoriesM151,869$44.4458,330Form 4
2026-08-25Abbott LaboratoriesM246,963$59.94705,293Form 4
2026-08-25Abbott LaboratoriesS218,535$115.57486,758Form 4
2026-08-25Abbott LaboratoriesS180,297$116.19306,461Form 4

Questions

What stock did Ford Robert B buy or sell?

Ford Robert B reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($46.2M), across 1 company.

Is Ford Robert B the same person as other filers with this name?

This page covers SEC CIK 1612571 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/ford-robert-b-1612571.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.